Breast Cancer Detection With 99m-Tc-Sestamibi Scintigraphy, Mammography, and Fine-Needle Aspiration Cytology: Comparative Study in 64 Surgically Treated Patients
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Background: In breast cancer, mammography (MG) fails to reveal malignancy in 10% to 15% of patients, and its sensitivity is limited by dense breast tissue. The aim of this study was to evaluate the usefulness of 99m-Tc-sestamibi scintimammography (SMM) in conjunction with MG and fine needle aspiration (FNA) cytology in the detection of low-stage breast cancer.
Methods: A total of 64 women (median age 58 years, range 32–86 years), 53 (82.8%) with palpable and 11 (17.2%) with nonpalpable breast mass, underwent SMM; 61 patients had MG and 62 underwent FNA cytology. At histological examination, breast cancer was found in 59 (92.2%) of the women (pTis = 2, pT1a = 2, pT1b = 13, pT1c = 20, pT2 = 22).
Results: Of the 61 patients who had MG, 45 (73.8%) showed signs of cancer or abnormalities. Of the 62 patients who had FNA cytology, 55 (88.7%) showed malignancy. In 5 (8.1%) patients, atypical ductal hyperplasia or complex sclerosing lesions were found. MG, SMM, and FNA cytology were 80.4%, 78.0%, and 96.5% sensitive, respectively, and their positive predictive value was 97.8%, 100%, and 100%, respectively. In all patients, cancer was at least detected by one of these three techniques.
Conclusions: In women with suspicious MG or abnormal FNA cytology that required further investigations, SMM may be helpful in surgical planning and should be considered in most patients before biopsy as an additional noninvasive procedure.
- Fiorica JV. Breast cancer. In: Leppert PC, Howard FM eds. Primary care for women. Philadelphia: Lippincot-Raven, 1997:198–202.
- Parker, SL, Tong, T, Bolden, S, Wingo, PA (1996) Cancer statistics. CA Cancer J Clin 46: pp. 5-27
- Flanagan, DA, Gladding, SB, Lovell, FR (1998) Can scintimammography reduce “unnecessary” biopsies?. Am Surg 64: pp. 670-672
- Kopans, DB (1992) The positive predictive value of mammography. Am J Radiol 158: pp. 521-526
- Dierks, DB, Katy, B (1994) Lawsuits for failure to diagnose breast cancer: tumor biology in causation and risk management strategies. Surg Oncol North Am 3: pp. 125-139
- McKenna, R (1994) The abnormal mammogram Radiographic findings, diagnostic options, pathology and stage of cancer diagnosis. Cancer 74: pp. 244-255
- Bird, RE, Wallace, TW, Yankaskas, BC (1992) Analysis of cancers missed at the screening mammography. Radiology 184: pp. 613-617
- Villanueva-Meyer, J, Leonard, MH, Briscoe, E, Cesani, F, Ali, SA, Rhoden, S, Hove, M, Cown, D (1996) Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer. J Nucl Med 37: pp. 926-930
- Clifford, EJ, Lugo-Zamudio, C (1996) Scintimammography in the diagnosis of breast cancer. Am J Surg 172: pp. 483-486
- Kao, CH, Wang, SJ, Liu, TJ (1994) The use of technetium-99m methoxyisobutylisonitsile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 21: pp. 432-436
- Taillefer, R, Robidoux, A, Lambert, R, Turpin, S, Laperrie‘re, J (1995) Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 36: pp. 1758-1765
- Waxman, AD, Ramanna, L, Memsic, LD (1993) Thallium scintigraphy in the evaluation of mass abnormalities of the breast. J Nucl Med 34: pp. 18-23
- Aigner, RM, Fueger, GF (1997) First experience with technetium-99m furifosmin as tumour-seeking agent in breast cancer and recurrent ovarian cancer. Eur J Nucl Med 24: pp. 1167-1170
- Ambrus, E, Rajtar, M, Ormandi, K, Toszegi, A, Lang, J, Pavics, L, Cserenay, L (1997) Value of 99m-TcMIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions. Anticancer Res 17: pp. 1599-1605
- Scopinaro, F, Schillaci, O, Ussof, W (1997) A three center study on the diagnostic accuracy of 99mTc-MIBI scintimammography. Anticancer Res 17: pp. 1631-1634
- Uriate, I, Carril, JM, Quirce, R (1998) Optimization of X-ray mammography and technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of non-palpable breast lesions. Eur J Nucl Med 25: pp. 491-496
- Carril, JM, Go‘mez-Barquı‘n, R, Quirce, R, Tabulenca, O, Uriate, I, Montero, A (1997) Contribution of Tc-MIBI scintimammography in the diagnosis of non-palpable breast lesions in relation to mammographic probability of malignancy. Anticancer Res 17: pp. 1677-1682
- Staren, ED (1996) Ultrasound-guided biopsy of nonpalpable breast masses by surgeons. Ann Surg Oncol 3: pp. 476-482
- Cross, MJ, Evans, WP, Peters, GN, Cheek, JH, Jones, RC, Krakos, P (1995) Stereotactic breast biopsy as an alternative to open excisional biopsy. Ann Surg Oncol 2: pp. 195-200
- Cutrone, JA, Yospur, LS, Khalkhali, I (1998) Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions. J Nucl Med 39: pp. 449-453
- Breast Cancer Detection With 99m-Tc-Sestamibi Scintigraphy, Mammography, and Fine-Needle Aspiration Cytology: Comparative Study in 64 Surgically Treated Patients
Annals of Surgical Oncology
Volume 6, Issue 6 , pp 568-571
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Breast cancer
- Industry Sectors
- Author Affiliations
- 1. Endocrine Surgery Unit, Department of Surgical and Gastroenterological Sciences, University of Padua, School of Medicine, Via Giustiniani 2, 35128, Padua, Padova, Italy
- 4. Endocrine Surgery Unit, Department of Surgical and Gastroenterological Sciences, University of Padua, Via Giustiniani 2, 35128, Padova, Italy
- 2. Department of Nuclear Medicine, University of Padua, School of Medicine, Via Giustiniani 2, 35128, Padua, Padova, Italy
- 3. Nuclear Medicine, Abano Terme Hospital, Padova, Italy